Meta-omics Portal for Metabolic Dysfunction-Associated Steatotic Liver Disease

This portal integrates multi-cohort transcriptomic meta-analyses and genetics evidence for metabolic dysfunction-associated steatotic liver disease (MASLD). For any gene or pathway, it provides stage-resolved differential expression meta-analysis, gene/pathway–clinical correlation patterns, and orthogonal genetic support.

Fibrosis and MASLD progression are summarized using random-effects meta-analysis across multiple liver cohorts, visualized as study-level forest plots. Clinical radar panels quantify how genes and pathways correlate with metabolic and histological traits, while the genetics panel aggregates GWAS/TWAS/SMR/PWAS/PheWAS signalss to help prioritize putative causal regulators for experimental follow-up.